Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Lippman

Showing results (281-290 of 340) with videos related to

Pageof 34
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2012
Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasterideAlan R Kristal, Cathee Till, Catherine M Tangen, et al.
The Lancet. Oncology|May 14, 2021
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trialAssuntina G Sacco, Ruifeng Chen, Francis P Worden, et al.
Nature Cell Biology|April 22, 2014
An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibitionLaetitia Seguin, Shumei Kato, Aleksandra Franovic, et al.
Lancet (London, England)|November 26, 2008
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trialEdward S Kim, Vera Hirsh, Tony Mok, et al.
Oncology|July 3, 2009
Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experienceJames D Cox, Sergio A Giralt, Mary L Veazie, et al.
Nature Medicine|April 24, 2019
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT studyJason K Sicklick, Shumei Kato, Ryosuke Okamura, et al.
Journal of the National Cancer Institute|December 22, 2005
In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysisLi-E Wang, Ping Xiong, Sara S Strom, et al.
Breast Cancer Research and Treatment|June 12, 2016
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancerBanu K Arun, Yun Gong, Diane Liu, et al.
Genome Medicine|October 5, 2021
Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve studyJason K Sicklick, Shumei Kato, Ryosuke Okamura, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 19, 2025
Genome-wide CRISPR screening reveals a PKA-driven resistance mechanism to metformin for oral cancer prevention that can be exploited by combination with NSAIDsThomas S Hoang, Farhoud Faraji, Amaya N Mendez-Molina, et al.
Pageof 34

Showing results (281-290 of 340) with videos related to

Sort By:
Pageof 34
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2012
Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasterideAlan R Kristal, Cathee Till, Catherine M Tangen, et al.
The Lancet. Oncology|May 14, 2021
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trialAssuntina G Sacco, Ruifeng Chen, Francis P Worden, et al.
Nature Cell Biology|April 22, 2014
An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibitionLaetitia Seguin, Shumei Kato, Aleksandra Franovic, et al.
Lancet (London, England)|November 26, 2008
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trialEdward S Kim, Vera Hirsh, Tony Mok, et al.
Oncology|July 3, 2009
Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experienceJames D Cox, Sergio A Giralt, Mary L Veazie, et al.
Nature Medicine|April 24, 2019
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT studyJason K Sicklick, Shumei Kato, Ryosuke Okamura, et al.
Journal of the National Cancer Institute|December 22, 2005
In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysisLi-E Wang, Ping Xiong, Sara S Strom, et al.
Breast Cancer Research and Treatment|June 12, 2016
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancerBanu K Arun, Yun Gong, Diane Liu, et al.
Genome Medicine|October 5, 2021
Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve studyJason K Sicklick, Shumei Kato, Ryosuke Okamura, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 19, 2025
Genome-wide CRISPR screening reveals a PKA-driven resistance mechanism to metformin for oral cancer prevention that can be exploited by combination with NSAIDsThomas S Hoang, Farhoud Faraji, Amaya N Mendez-Molina, et al.
Pageof 34